PRESS RELEASES

All Releases
Jul 10, 2001
Pain Therapeutics Announces Inclusion in Russell 3000 Index SOUTH SAN FRANCISCO, Calif., Jul 10, 2001 (BW HealthWire) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a developer of next-generation opioid painkillers, today announced that its common stock has been added to the Russell 3000(R) Index, a
Apr 20, 2001
Pain Therapeutics to Present at the 20th Annual Scientific Meeting of the American Pain Society SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--April 20, 2001--Pain Therapeutics, Inc. (Nasdaq:PTIE), a developer of next-generation opioid painkillers, today announced that it will lead a symposium at
Apr 02, 2001
Pain Therapeutics Adds Drug Candidate to Its Pipeline SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--April 2, 2001--Pain Therapeutics, Inc. (Nasdaq:PTIE), a developer of novel prescription painkillers, announced today that it has added a fifth drug candidate, PTI-801, to its pipeline.
Mar 01, 2001
Pain Therapeutics, Inc. Conference Call Notice SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--March 1, 2001-- Management of Pain Therapeutics, Inc. (PTIE) is holding a conference call/Web cast to discuss fourth quarter and year-end 2000 results. THE CONFERENCE CALL WILL BE HELD: THURSDAY, MARCH 8,
Jan 08, 2001
Pain Therapeutics Announces Extension of Lock-Up Agreement SOUTH SAN FRANCISCO, Calif. - January 8, 2001 - Pain Therapeutics, Inc. (Nasdaq:PTIE), a developer of next generation opioid painkillers, today announced that officers, directors and venture capital investors who are principal shareholders
Oct 23, 2000
Pain Therapeutics Announces Positive Phase II Data for New Type of Morphine and Initiates Two New Phase II Clinical Trials SOUTH SAN FRANCISCO, Calif. - October 23, 2000 - Pain Therapeutics, Inc. (Nasdaq: PTIE) announced today that it has initiated two Phase IIb clinical trials on PTI-555, the
Oct 18, 2000
Pain Therapeutics Initiates Phase II Clinical Trial for New Painkiller SOUTH SAN FRANCISCO, Calif. - October 18, 2000 - Pain Therapeutics, Inc. (Nasdaq: PTIE), a developer of next-generation opioid pain medications, announced today the initiation of a Phase IIb clinical trial with PTI-601.
Oct 03, 2000
Pain Therapeutics Announces Positive Phase II Clinical Results for a New Type of Painkiller South San Francisco, Calif. - October 3, 2000 - Pain Therapeutics, Inc. (Nasdaq: PTIE), a developer of next generation opioid painkillers, today announced positive safety and efficacy results from a Phase II